Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
Cash Flow Statement
Cash Flow Statement
Shandong Keyuan Pharmaceutical Co Ltd
| Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Cash Taxes Paid |
(30)
|
(25)
|
(21)
|
(32)
|
(30)
|
(19)
|
(12)
|
(10)
|
(12)
|
|
| Change in Working Capital |
(133)
|
(159)
|
(170)
|
(211)
|
(184)
|
(269)
|
(280)
|
(260)
|
(245)
|
|
| Cash from Operating Activities |
60
N/A
|
37
-38%
|
21
-43%
|
41
+92%
|
42
+3%
|
(61)
N/A
|
(59)
+2%
|
(53)
+11%
|
(57)
-8%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(38)
|
(70)
|
(143)
|
(220)
|
(249)
|
(296)
|
(246)
|
(224)
|
(191)
|
|
| Other Items |
(546)
|
(532)
|
(236)
|
(502)
|
179
|
109
|
(188)
|
232
|
(77)
|
|
| Cash from Investing Activities |
(584)
N/A
|
(602)
-3%
|
(379)
+37%
|
(723)
-91%
|
(70)
+90%
|
(188)
-168%
|
(434)
-131%
|
8
N/A
|
(268)
N/A
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
0
|
783
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
46
|
67
|
96
|
98
|
|
| Cash Paid for Dividends |
(31)
|
(31)
|
0
|
(63)
|
(33)
|
(33)
|
0
|
(22)
|
(24)
|
|
| Other |
772
|
(12)
|
(11)
|
(11)
|
(1)
|
2
|
(5)
|
0
|
0
|
|
| Cash from Financing Activities |
741
N/A
|
740
0%
|
(42)
N/A
|
(74)
-77%
|
(33)
+55%
|
15
N/A
|
30
+96%
|
75
+154%
|
75
-1%
|
|
| Change in Cash | ||||||||||
| Effect of Foreign Exchange Rates |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Net Change in Cash |
217
N/A
|
175
-19%
|
(399)
N/A
|
(756)
-89%
|
(61)
+92%
|
(232)
-283%
|
(463)
-99%
|
31
N/A
|
(249)
N/A
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
22
N/A
|
(33)
N/A
|
(122)
-269%
|
(179)
-47%
|
(207)
-15%
|
(357)
-73%
|
(306)
+14%
|
(277)
+9%
|
(248)
+10%
|
|